Galactosaemia Presenting As Congenital Pseudoafibrinogenaemia
  Overview
        Overview
  Authors
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Citing Articles
                              The Importance of Neonatal Screening for Galactosemia.
Tisa I, Achim A, Cozma-Petrut A Nutrients. 2023; 15(1).
PMID: 36615667 PMC: 9823668. DOI: 10.3390/nu15010010.
Nguyen T, Le Q, Hoang D, Nguyen H, Thi Ha T, Nguyen M Mol Genet Genomic Med. 2022; 10(7):e1959.
PMID: 35502621 PMC: 9266602. DOI: 10.1002/mgg3.1959.
Ganjekarimi A, Senemar S, Tarami B, Bazrgar M Iran J Public Health. 2012; 40(4):99-104.
PMID: 23113108 PMC: 3481732.
  References
                              1.
  
    Lauras B, Barriere C, FREYCON M, Teyssier G, Freycon F
    
    . [Anomalies of hemostasis during the neonatal period in 4 cases of congenital galactosemia]. Pediatrie. 1983; 38(1):23-8.
    
    
    View
  
2.
  
    HOLTON J
    
    . Galactosaemia: pathogenesis and treatment. J Inherit Metab Dis. 1996; 19(1):3-7.
    
          DOI: 10.1007/BF01799341.
    
    View
  
3.
  
    Levy H, Brown A, Williams S, de Juan Jr E
    
    . Vitreous hemorrhage as an ophthalmic complication of galactosemia. J Pediatr. 1996; 129(6):922-5.
    
          DOI: 10.1016/s0022-3476(96)70041-0.
    
    View